Operating Lease, Right-of-Use Asset of CG Oncology, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: CG Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
CG Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,203,000, a 1428% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CG Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$4,203,000	+$3,928,000	+1428%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$965,000	+$636,000	+193%	30 Jun 2025	10-Q	08 Aug 2025	2025	Q2
Q1 2025	$1,033,000	+$665,000	+181%	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q4 2024	$221,000	-$201,000	-48%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$275,000			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$329,000			30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$368,000			31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$422,000			31 Dec 2023	10-K	28 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.